Stocks / NASDAQ / Silence Therapeutics Plc

Silence Therapeutics Plc

Our Opinion

Silence Therapeutics Plc is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of its medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

“This approach enables Silence to replace or restore gene expression in pre-clinical animal models, in addition to its existing capability to silence overexpressed genes with its short-interfering RNA (siRNA) platform.” Read the following article

Company Description

Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company’s platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated genes in the liver. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc is headquartered in London, the United Kingdom.

Company Website: